Chelsey Porter Erlank

Datos Biográficos

ID9068665
NOMBREChelsey Porter Erlank
NOMBRESChelsey Porter
APELLIDOErlank
FIRMAERLANK C P
AFILIACIONESClinton Health Access Initiative
ORCID0000-0001-7588-0565
VERIFICADOSí
TOTAL DE OBRAS4
TOTAL DE CITAS0
TOTAL COMO AUTOR4
TOTAL COMO EDITOR0
PRIMER AÑO DE PUBLICACIÓN2023
AÑO MÁS RECIENTE DE PUBLICACIÓN2026
ÍNDICE H0

  • ‘ I am now confident in the counseling and in inserting the loop’

    Open AccessAmani Kikula, Jackline E Ngowi et al.ARTICLEGlobal Health Action2026

    BACKGROUND: Unmet need for contraception among women is high in Tanzania. Hormonal intrauterine device was not among the contraceptives offered in public health facilities in Tanzania until a Ministry of Health pilot in 2023-2024. OBJECTIVE: Explore the feasibility of providing hormonal intrauterine devices in public health facilities in Tanzania. METHODS: An observational exploratory mixed-methods study design was conducted, using cross-sectiona…

  • “ I just love it - I know there is something which has not given me worry when I am with my partner ”

    Open AccessChelsey Porter Erlank, Amani Kikula et al.ARTICLEGlobal Health Action2026

    BACKGROUND: Hormonal intrauterine device (IUD) is an effective contraceptive method with high user satisfaction rates. To guide the introduction of hormonal IUD into the public sector in Tanzania, an operational research study was conducted to assess client acceptability of hormonal IUDs. OBJECTIVE: To explore clients' perspectives on contraceptives and experiences with hormonal IUDs. METHODS: = 15 at endline) with hormonal IUD clients. Register …

  • Consistency of on-the-job training implementation for subcutaneous depot medroxyprogesterone acetate in Ghana and associated healthcare worker knowledge transfer

    Open AccessChelsey Porter Erlank, Mensimah Bentsi-Enchill et al.ARTICLEPLOS Global Public Health2026

    Subcutaneous depot medroxyprogesterone acetate, or DMPA-SC, is an injectable contraceptive that can be administered by any trained person, including for self-injection. When scaling in-service healthcare worker training on DMPA-SC between 2019 and 2021, Ghana Health Service tasked a cohort of formally-trained healthcare workers to transfer their training ‘on-the-job’ to colleagues at their facilities, to save costs while improving training covera…

  • Health care provider and client experiences of counselling on depot medroxyprogesterone acetate subcutaneous (DMPA-SC) for self-injection in Malawi

    Open AccessChelsey Porter Erlank, Gracious Ali et al.ARTICLEPLOS Global Public Health2023

    Since the introduction of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) in 2018, Malawi has achieved national coverage of trained providers in the public sector and steady increases in uptake of DMPA-SC. However, the rate of clients opting to self-inject DMPA-SC has remained lower than early acceptability studies suggested. Providers play an instrumental role in building client confidence to self-inject through counselling/training. Th…